Compounds > deferasirox
Page last updated: 2024-09-05

deferasirox and Infections, Vibrio

deferasirox has been researched along with Infections, Vibrio in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, HS; Kang, JI; Kim, DM; Kim, HS; Park, CY1
Kim, DM; Neupane, GP2

Other Studies

3 other study(ies) available for deferasirox and Infections, Vibrio

ArticleYear
Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction.
    The Journal of infection, 2008, Volume: 57, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Benzoates; Ciprofloxacin; Deferasirox; DNA, Bacterial; Drug Therapy, Combination; Female; Hemochromatosis; Humans; Polymerase Chain Reaction; Sepsis; Triazoles; Vibrio Infections; Vibrio vulnificus

2008
Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus.
    Transfusion, 2009, Volume: 49, Issue:8

    Topics: Benzoates; Deferasirox; Deferiprone; Deferoxamine; Humans; Iron Overload; Pyridones; Siderophores; Triazoles; Vibrio Infections; Vibrio vulnificus

2009
In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4

    Topics: Anti-Bacterial Agents; Benzoates; Chelating Agents; Ciprofloxacin; Deferasirox; Drug Synergism; Hospitals; Humans; Microbial Sensitivity Tests; Microbial Viability; Republic of Korea; Time Factors; Triazoles; Vibrio Infections; Vibrio vulnificus

2010